NewGenIvf Group Limited (NIVF) Balance Sheet
NIVF balance sheet, 2025
December 31, 2025 · U.S. dollars$32.7M assets = $6.7M liabilities + $26.0M equity
Both columns are drawn to the same scale: what NIVF owns equals what it owes plus shareholders’ equity. Hover a block for its value.
NIVF financial health
Descriptive bands, not a rating. Fiscal 2025.
NIVF balance sheet trends, 2021–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1.4M2021 | $32.7M2025 | +119.4%/yr | |
| Total liabilities | $2.3M2021 | $6.7M2025 | +30.4%/yr | |
| Shareholders’ equity | −$775,9382021 | $26.6M2025 | — | |
| Cash & short-term investments | $28,7642021 | $758,6212025 | +126.6%/yr | |
| Total debt | $925,9682021 | $4.9M2025 | +51.4%/yr | |
| Net cash (debt) | −$897,2042021 | −$4.1M2025 | −$3.2M | |
| Working capital | −$1.2M2021 | $5.0M2025 | +$6.3M | |
| Current ratio | 0.402021 | 3.122025 | +2.72 | |
| Debt / equity | 0.802022 | 0.182025 | −0.62 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
NIVF assets
NIVF liabilities and equity
NIVF debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
NIVF balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & short-term investments | $758,621 | $457,740 | $42,224 | $27,556 | $28,764 |
| Cash & equivalents | $758,621 | $457,740 | $42,224 | $27,556 | $28,764 |
| Short-term investments | — | $11,880 | — | — | — |
| Receivables | $1.1M | $2.4M | $1.0M | $2.3M | $750,351 |
| Inventory | $335,360 | $80,813 | $126,264 | $46,910 | $41,271 |
| Other current assets | $5.2M | $271,623 | $0 | $0 | $0 |
| Total current assets | $7.4M | $3.2M | $50,780 | $2.4M | $820,386 |
| Property, plant & equipment (net) | $2.3M | $371,666 | $446,004 | $506,343 | $592,378 |
| Goodwill & intangible assets | $23.0M | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $33,333 | $20.8M | $0 | $0 |
| Total assets | $32.7M | $3.6M | $21.3M | $2.9M | $1.4M |
| Liabilities | |||||
| Accounts payable | $779,280 | $1.3M | $172,626 | $104,651 | $46,927 |
| Short-term debt | $494,161 | $690,973 | $1.6M | $203,409 | $664,146 |
| Deferred revenue | $111,981 | $63,489 | $7,937 | $1.4M | $812,158 |
| Total current liabilities | $2.4M | $2.7M | $2.2M | $2.6M | $2.1M |
| Long-term debt | $4.1M | $2.3M | $0 | $0 | $0 |
| Lease obligations | $510,464 | $118,757 | $332,553 | $452,042 | $413,147 |
| Other long-term liabilities | $272,359 | $10,231 | $3.5M | $248,633 | $261,822 |
| Total liabilities | $6.7M | $5.1M | $5.7M | $2.8M | $2.3M |
| Shareholders' equity | |||||
| Common stock & paid-in capital | — | $21.3M | $21.3M | $6,018 | $5,600 |
| Retained earnings (deficit) | $8.9M | −$985,994 | −$5.7M | −$591,544 | −$1.1M |
| Accumulated other comprehensive income | −$143,071 | $18,875 | −$7,288 | $9,570 | $10,852 |
| Minority interest | −$644,826 | −$433,143 | −$490,051 | −$462,430 | — |
| Total shareholders' equity | $26.6M | −$1.0M | $15.6M | $563,113 | −$775,938 |
| Key figures | |||||
| Total debt | $4.9M | $3.0M | $1.6M | $452,042 | $925,968 |
| Net cash (debt) | −$4.1M | −$2.6M | −$1.6M | −$424,486 | −$897,204 |
| Working capital | $5.0M | $452,391 | −$2.2M | −$157,027 | −$1.2M |
| Tangible book value | $3.6M | −$1.0M | $15.6M | $563,113 | −$775,938 |
| Book value per share | — | — | $2.87 | — | — |
| Shares outstanding | — | — | 5.4M | — | — |
| Current ratio | 3.12 | 1.17 | 0.02 | 0.94 | 0.40 |
| Quick ratio | 0.77 | 1.04 | 0.47 | 0.92 | 0.38 |
| Debt / equity | 0.18 | — | 0.10 | 0.80 | — |
| Equity / assets | 81.4% | −29.3% | 73.2% | 19.4% | −54.9% |
| Dec '25 | Sep '25 | Mar '25 | Sep '24 | Jun '24 | Dec '23 | Sep '23 | Jun '23 | Dec '22 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & short-term investments | $758,621 | $295,289 | $457,740 | $169,661 | $54,104 | $42,224 | $39.3M | $77,294 | $27,556 |
| Cash & equivalents | $758,621 | $295,289 | $457,740 | $169,661 | $54,104 | $42,224 | $38,754 | $77,294 | $27,556 |
| Short-term investments | — | — | — | — | $11,880 | — | $39.3M | $38.5M | — |
| Receivables | $1.1M | $2.5M | $1.4M | $354,097 | $519,555 | $1.0M | $0 | $898,298 | $2.3M |
| Inventory | $335,360 | $86,977 | $80,813 | $238,864 | $126,264 | $126,264 | $0 | $68,050 | $46,910 |
| Other current assets | $5.2M | $2.7M | $1.3M | $214,937 | $1.8M | $0 | $49,189 | $0 | $0 |
| Total current assets | $7.4M | $5.6M | $3.2M | $977,559 | $2.5M | $50,780 | $39.3M | $1.0M | $2.4M |
| Property, plant & equipment (net) | $2.3M | $1.2M | $371,666 | $486,362 | $446,004 | $446,004 | $0 | $405,998 | $506,343 |
| Goodwill & intangible assets | $23.0M | $24.2M | $0 | $2,698 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $532,712 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $4.1M | $237,333 | $6,047 | $1.6M | $20.8M | $0 | $0 | $0 |
| Total assets | $32.7M | $35.6M | $3.8M | $1.5M | $4.5M | $21.3M | $39.3M | $1.4M | $2.9M |
| Liabilities | |||||||||
| Accounts payable | $779,280 | $797,718 | $1.3M | $2.1M | $172,626 | $172,626 | — | $152,318 | $104,651 |
| Short-term debt | $494,161 | $305,518 | $690,973 | $213,546 | $213,574 | $1.6M | $1.4M | $196,043 | $203,409 |
| Deferred revenue | $111,981 | $67,401 | $63,489 | $8,400 | $7,937 | $7,937 | — | $109,268 | $1.4M |
| Total current liabilities | $2.4M | $1.6M | $2.7M | $3.5M | $1.1M | $2.2M | $4.4M | $1.3M | $2.6M |
| Long-term debt | $4.1M | $4.9M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $510,464 | $603,599 | — | — | — | $332,553 | — | $353,060 | $452,042 |
| Other long-term liabilities | $272,359 | $298,081 | $2.3M | $5.1M | $118,979 | $3.5M | $0 | $157,017 | $248,633 |
| Total liabilities | $6.7M | $6.8M | $5.1M | $8.5M | $1.2M | $5.7M | $4.4M | $1.5M | $2.8M |
| Shareholders' equity | |||||||||
| Common stock & paid-in capital | — | — | — | — | $21.3M | $21.3M | $39.3M | $6,018 | $6,018 |
| Retained earnings (deficit) | $8.9M | $16.6M | −$985,994 | −$8.0M | −$461,351 | −$5.7M | −$4.3M | −$899,441 | −$591,544 |
| Accumulated other comprehensive income | −$143,071 | −$249,711 | $18,875 | $3,370 | −$7,288 | −$7,288 | — | $37,785 | $9,570 |
| Minority interest | −$644,826 | −$636,797 | — | — | — | — | — | — | — |
| Total shareholders' equity | $26.6M | $29.4M | −$844,614 | −$6.6M | $3.7M | $15.6M | $34.9M | $475,739 | $563,113 |
| Key figures | |||||||||
| Total debt | $4.9M | $5.5M | $3.0M | $5.3M | $332,553 | $1.6M | $1.4M | $353,060 | $452,042 |
| Net cash (debt) | −$4.1M | −$5.2M | −$2.6M | −$5.1M | −$278,449 | −$1.6M | $37.9M | −$275,766 | −$424,486 |
| Working capital | $5.0M | $3.9M | $452,391 | −$2.5M | $1.3M | −$2.2M | $34.9M | −$296,883 | −$157,027 |
| Tangible book value | $3.6M | $5.1M | −$844,614 | −$6.6M | $3.7M | $15.6M | $34.9M | $475,739 | $563,113 |
| Book value per share | — | — | — | — | — | $4.19 | — | — | — |
| Shares outstanding | — | — | — | — | — | 3.7M | — | — | — |
| Current ratio | 3.12 | 3.43 | 1.17 | 0.28 | 2.19 | 0.02 | 8.87 | 0.78 | 0.94 |
| Quick ratio | 0.77 | 1.72 | 0.67 | 0.15 | 0.51 | 0.47 | 8.86 | 0.73 | 0.92 |
| Debt / equity | 0.18 | 0.19 | — | — | 0.09 | 0.10 | 0.04 | 0.74 | 0.80 |
| Equity / assets | 81.4% | 82.6% | −22.3% | −447.1% | 83.3% | 73.2% | 88.7% | 32.8% | 19.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 31, 2026); data from EODHD.
NIVF financial position
At the end of fiscal 2025 (December 31, 2025), NewGenIvf had total assets of $32.7 million (up 814.6% from a year earlier), total liabilities of $6.7 million and shareholders' equity of $26.6 million. It held $0.8 million in cash and short-term investments against $4.9 million of debt, net debt of $4.1 million. Its current ratio was 3.12.
Related: NIVF income statement, NIVF cash flow statement, NIVF key metrics. See the NIVF stock overview for the latest quote and news.
NIVF balance sheet FAQ
What are NewGenIvf's total assets?
NewGenIvf reported total assets of $32.7 million at the end of fiscal 2025 (December 31, 2025), compared with $3.6 million a year earlier.
How much debt does NewGenIvf have?
NewGenIvf had $4.9 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.18.
How much cash does NewGenIvf have?
NewGenIvf held $0.8 million in cash and short-term investments at the end of fiscal 2025; with $4.9 million of debt that is net debt of $4.1 million.
What is NewGenIvf's book value?
NewGenIvf's shareholders' equity (book value) was $26.6 million at the end of fiscal 2025.
What is NewGenIvf's current ratio?
NewGenIvf had current assets of $7.4 million and current liabilities of $2.4 million, a current ratio of 3.12 (it can cover its short-term obligations).
How much goodwill does NewGenIvf have?
NewGenIvf carried $23.0 million of goodwill and intangible assets, 70.4% of total assets, at the end of fiscal 2025.